Developing a fast imaging technique for brain tumors using advanced MRI methods
Chemical Exchange Saturation Transfer MR Fingerprinting
['FUNDING_R01'] · JOHNS HOPKINS UNIVERSITY · NIH-10886553
This study is working on a new, faster way to take pictures of the brain that helps doctors find and understand brain tumors better, so they can plan the best treatment for patients like you.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10886553 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a rapid and quantitative imaging technique called chemical exchange saturation transfer (CEST) imaging, which will be integrated with MR fingerprinting and deep-learning methods. The goal is to improve the detection and characterization of brain tumors by providing detailed information about tissue properties, such as protein content and pH levels. By enhancing the speed and accuracy of imaging, this technique aims to facilitate better diagnosis and treatment planning for patients with brain tumors.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with brain tumors or those undergoing evaluation for brain cancer.
Not a fit: Patients with non-brain-related conditions or those who do not have tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely diagnoses of brain tumors, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using similar imaging techniques for tumor characterization, indicating potential for success in this novel approach.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HEO, HYE YOUNG — JOHNS HOPKINS UNIVERSITY
- Study coordinator: HEO, HYE YOUNG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Brain Cancer